Condition
Intensive Care Unit (ICU) Admission
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting2
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06726733CompletedPrimary
Assessing Intensive Care Unit (ICU) Indications: Human vs. ChatGPT-4o Predictions
NCT07481773Not ApplicableRecruitingPrimary
Biomarker Signature-Supported Antibiotic Treatment Decisions in ICU
NCT07435896Not Yet RecruitingPrimary
Impact of Information and Participation on Decision Time for Tracheostomy or PEG in ICU Families
NCT07176624Not ApplicableRecruiting
The PRE-VAIL Study
NCT07089693Completed
Acute Kidney Injury in Critical COVID-19: Outcomes and Risks
Showing all 5 trials